CN1416914A - Artificial biological canula and its making process - Google Patents
Artificial biological canula and its making process Download PDFInfo
- Publication number
- CN1416914A CN1416914A CN 01134542 CN01134542A CN1416914A CN 1416914 A CN1416914 A CN 1416914A CN 01134542 CN01134542 CN 01134542 CN 01134542 A CN01134542 A CN 01134542A CN 1416914 A CN1416914 A CN 1416914A
- Authority
- CN
- China
- Prior art keywords
- chitosan
- canula
- artificial biological
- calcium alginate
- alginic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- 239000000648 calcium alginate Substances 0.000 claims abstract description 60
- 229960002681 calcium alginate Drugs 0.000 claims abstract description 60
- 238000009987 spinning Methods 0.000 claims abstract description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 14
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000000661 sodium alginate Substances 0.000 claims abstract description 13
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 13
- 238000011282 treatment Methods 0.000 claims abstract description 11
- 239000003814 drug Substances 0.000 claims abstract description 9
- 239000000126 substance Substances 0.000 claims abstract description 8
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims abstract description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 104
- 229920001661 Chitosan Polymers 0.000 claims description 83
- 229940053128 nerve growth factor Drugs 0.000 claims description 57
- 108010025020 Nerve Growth Factor Proteins 0.000 claims description 56
- 102000015336 Nerve Growth Factor Human genes 0.000 claims description 56
- 229920000615 alginic acid Polymers 0.000 claims description 42
- 235000010443 alginic acid Nutrition 0.000 claims description 41
- 239000000783 alginic acid Substances 0.000 claims description 40
- 229960001126 alginic acid Drugs 0.000 claims description 40
- 150000004781 alginic acids Chemical class 0.000 claims description 40
- 239000000243 solution Substances 0.000 claims description 35
- 235000010410 calcium alginate Nutrition 0.000 claims description 33
- OKHHGHGGPDJQHR-YMOPUZKJSA-L calcium;(2s,3s,4s,5s,6r)-6-[(2r,3s,4r,5s,6r)-2-carboxy-6-[(2r,3s,4r,5s,6r)-2-carboxylato-4,5,6-trihydroxyoxan-3-yl]oxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylate Chemical compound [Ca+2].O[C@@H]1[C@H](O)[C@H](O)O[C@@H](C([O-])=O)[C@H]1O[C@H]1[C@@H](O)[C@@H](O)[C@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@H](O2)C([O-])=O)O)[C@H](C(O)=O)O1 OKHHGHGGPDJQHR-YMOPUZKJSA-L 0.000 claims description 33
- 239000007864 aqueous solution Substances 0.000 claims description 31
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical group CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 24
- 230000001537 neural effect Effects 0.000 claims description 19
- 230000001112 coagulating effect Effects 0.000 claims description 17
- 238000002360 preparation method Methods 0.000 claims description 17
- 238000005406 washing Methods 0.000 claims description 17
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 15
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 15
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims description 12
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 claims description 11
- 239000001110 calcium chloride Substances 0.000 claims description 11
- 229910001628 calcium chloride Inorganic materials 0.000 claims description 11
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 238000004519 manufacturing process Methods 0.000 claims description 10
- 230000007935 neutral effect Effects 0.000 claims description 10
- 230000006196 deacetylation Effects 0.000 claims description 9
- 238000003381 deacetylation reaction Methods 0.000 claims description 9
- 238000002347 injection Methods 0.000 claims description 9
- 239000007924 injection Substances 0.000 claims description 9
- 210000004116 schwann cell Anatomy 0.000 claims description 9
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- 230000007547 defect Effects 0.000 claims description 8
- 230000000694 effects Effects 0.000 claims description 8
- 239000000835 fiber Substances 0.000 claims description 8
- 238000001467 acupuncture Methods 0.000 claims description 7
- 230000003115 biocidal effect Effects 0.000 claims description 7
- 238000004108 freeze drying Methods 0.000 claims description 7
- 230000018044 dehydration Effects 0.000 claims description 6
- 238000006297 dehydration reaction Methods 0.000 claims description 6
- 238000012805 post-processing Methods 0.000 claims description 6
- 239000011780 sodium chloride Substances 0.000 claims description 6
- 239000000052 vinegar Substances 0.000 claims description 6
- 235000021419 vinegar Nutrition 0.000 claims description 6
- 239000011259 mixed solution Substances 0.000 claims description 5
- 238000006424 Flood reaction Methods 0.000 claims description 4
- 241001465754 Metazoa Species 0.000 claims description 4
- 230000009286 beneficial effect Effects 0.000 claims description 4
- 239000000701 coagulant Substances 0.000 claims description 4
- 230000015271 coagulation Effects 0.000 claims description 4
- 238000005345 coagulation Methods 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000010790 dilution Methods 0.000 claims description 3
- 239000012895 dilution Substances 0.000 claims description 3
- 238000007598 dipping method Methods 0.000 claims description 3
- 235000012489 doughnuts Nutrition 0.000 claims description 3
- 238000005470 impregnation Methods 0.000 claims description 3
- 229950000845 politef Drugs 0.000 claims description 3
- 230000001954 sterilising effect Effects 0.000 claims description 3
- 238000004659 sterilization and disinfection Methods 0.000 claims description 3
- 238000003756 stirring Methods 0.000 claims description 3
- 102100024785 Fibroblast growth factor 2 Human genes 0.000 claims 2
- 210000005036 nerve Anatomy 0.000 abstract description 24
- 239000000463 material Substances 0.000 abstract description 11
- 206010061218 Inflammation Diseases 0.000 abstract description 8
- 230000004054 inflammatory process Effects 0.000 abstract description 8
- 238000010521 absorption reaction Methods 0.000 abstract description 6
- 230000012010 growth Effects 0.000 abstract description 6
- 238000006243 chemical reaction Methods 0.000 abstract description 3
- 230000001737 promoting effect Effects 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- SRIQFCJARAPHRI-UHFFFAOYSA-N Alginin Natural products COc1cc(O)c2C(=O)C(=C(Oc2c1O)c3ccc(OC4OC(C(O)C(O)C4O)C(=O)O)cc3)O SRIQFCJARAPHRI-UHFFFAOYSA-N 0.000 abstract 1
- VDDRNXHIJFHESZ-UHFFFAOYSA-L calcium dichloride hydrochloride Chemical compound Cl.[Cl-].[Cl-].[Ca+2] VDDRNXHIJFHESZ-UHFFFAOYSA-L 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 239000012510 hollow fiber Substances 0.000 abstract 1
- 230000036228 toxication Effects 0.000 abstract 1
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 description 10
- 210000000578 peripheral nerve Anatomy 0.000 description 8
- 108010083674 Myelin Proteins Proteins 0.000 description 6
- 102000006386 Myelin Proteins Human genes 0.000 description 6
- 229940125904 compound 1 Drugs 0.000 description 6
- 210000005012 myelin Anatomy 0.000 description 6
- 210000003666 myelinated nerve fiber Anatomy 0.000 description 6
- 230000008929 regeneration Effects 0.000 description 6
- 238000011069 regeneration method Methods 0.000 description 6
- 210000000988 bone and bone Anatomy 0.000 description 5
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 5
- -1 Polyoxyethylene Polymers 0.000 description 4
- 210000000589 cicatrix Anatomy 0.000 description 4
- 239000012530 fluid Substances 0.000 description 4
- 238000001727 in vivo Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 229920002101 Chitin Polymers 0.000 description 3
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 3
- 210000004345 peroneal nerve Anatomy 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 241000199919 Phaeophyceae Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 229940072056 alginate Drugs 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- 238000007334 copolymerization reaction Methods 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 210000001503 joint Anatomy 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920005615 natural polymer Polymers 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 229920000867 polyelectrolyte Polymers 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 230000002980 postoperative effect Effects 0.000 description 2
- 230000011514 reflex Effects 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 210000002027 skeletal muscle Anatomy 0.000 description 2
- 229920001059 synthetic polymer Polymers 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- AEMOLEFTQBMNLQ-BZINKQHNSA-N D-Guluronic Acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@@H](O)[C@H]1O AEMOLEFTQBMNLQ-BZINKQHNSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-VANFPWTGSA-N D-mannopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-VANFPWTGSA-N 0.000 description 1
- 241000238557 Decapoda Species 0.000 description 1
- 241000371997 Eriocheir sinensis Species 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 description 1
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acetylhexosamine Chemical group CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 208000001738 Nervous System Trauma Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000010886 Peripheral nerve injury Diseases 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920000954 Polyglycolide Polymers 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 102000013275 Somatomedins Human genes 0.000 description 1
- PJANXHGTPQOBST-VAWYXSNFSA-N Stilbene Natural products C=1C=CC=CC=1/C=C/C1=CC=CC=C1 PJANXHGTPQOBST-VAWYXSNFSA-N 0.000 description 1
- 239000004809 Teflon Substances 0.000 description 1
- 229920006362 Teflon® Polymers 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 229920006243 acrylic copolymer Polymers 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 230000000680 avirulence Effects 0.000 description 1
- AEMOLEFTQBMNLQ-UHFFFAOYSA-N beta-D-galactopyranuronic acid Natural products OC1OC(C(O)=O)C(O)C(O)C1O AEMOLEFTQBMNLQ-UHFFFAOYSA-N 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 229940045110 chitosan Drugs 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007831 electrophysiology Effects 0.000 description 1
- 238000002001 electrophysiology Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000003364 immunohistochemistry Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000002406 microsurgery Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 125000002270 phosphoric acid ester group Chemical group 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 229920006149 polyester-amide block copolymer Polymers 0.000 description 1
- 239000004633 polyglycolic acid Substances 0.000 description 1
- 239000004626 polylactic acid Substances 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- PJANXHGTPQOBST-UHFFFAOYSA-N stilbene Chemical compound C=1C=CC=CC=1C=CC1=CC=CC=C1 PJANXHGTPQOBST-UHFFFAOYSA-N 0.000 description 1
- 235000021286 stilbenes Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 210000003462 vein Anatomy 0.000 description 1
Landscapes
- Materials For Medical Uses (AREA)
Abstract
The artificial biological canula is made using sodium alginate as main material, the water solution of hydrochloric acid-calcium chloride as solidifying agent, and through hollow fiber spinning and drawing process to produce hollow circular alginin acid-calcium alginate tube with desired size and physical and mechanical performance; chemical treatment of the tube with chitinamine solution to produce artificial biological canula with excellent normal saline resistance and proper absorption period. To the artificial biological canula, proper amount of nerve growth promoting factor may be added to prepare medicine slow-release artificial biological canula. The absorbable artificial biological canula has excellent biocompatibility, no toxic and inflammation reaction and controllable absorption period.
Description
Invention field
The present invention relates to a kind of artificial biological canula and manufacture method thereof, particularly a kind of alginic acid chitosan-calcium alginate is main component, the absorbability artificial biological canula and the manufacture method thereof that can guide and promote effective regeneration of nerve, belongs to biomedical materials field.
Prior art
Perineural damage very in clinical more to be seen, generally adopt at present epineurium or perineurium to sew up the method reparation of peripheral nerve injury clinically, but coincide with the corresponding of sensory tract because said method can't guarantee motor tract, repairing effect is unsatisfactory.
For the qualitative kiss that can carry out nerve tract in operation connects, people have carried out function of nervous system's bundle The Location from aspects such as anatomy and immunohistochemistries for many years, but all can't be applied to clinical up to now.The selectivity regeneration of Forssman and Cajal is theoretical, promptly reserves the regeneration that will help mixed nerve for the regenerated space of its selectivity between two broken ends of fractured bone of nerve butt joint; This is theoretical to be that new practical way has been pointed out in neural good butt joint, its method is called as little gap cover connection, confirmed by some experiments in recent years, as by from body tremulous pulse socket mixed nerve model, confirmed the superiority that regenerated objectivity of peripheral nerve selectivity and the socket of little gap are sewed up from many-sides such as microsurgery observation, histology, electrophysiology, nerve immunity chemistry.But can not use in clinical from the body tremulous pulse, autogenous vein also is difficult to extensive use in clinical.More satisfactory socket material should be artificial bio-membrane's material that a kind of biocompatibility is better, can absorb and have certain promotion and guiding neuranagenesis effect.
The material that is used at present to repair neurologic defect both at home and abroad has silica gel tube, teflon catheter, cellulosic casing etc., but all there is certain defective in these materials aspect absorbability and the histocompatibility, be difficult to be used widely clinically.
The patent that relates to the material that is used to repair neurologic defect mainly contains: WO9844020A1 and WO9844021A1 have reported that the synthetic polymer of phosphoric acid ester group can be used for making the conduit of nerve growth; US5844017A has reported that a kind of aliphatic Polyoxyethylene este prepolymer can prepare the conduit that is used for neural connection; Adopt synthetic polymer such as polylactic acid, polyglycolic acid, poly-(Acetic acid, hydroxy-, bimol. cyclic ester-lactide), polyesteramide and copolymerization thereof, blend to prepare nerve rehabilitating tube among the US4534349A; The fiber product of the polymer that adopts among US4669474A, US4883618A, US5147399A, the EP0327022A as adopt among the US4534349A is through filling the neural reparation that is used to rupture of film and bonding Processing of Preparation porous, shaggy conduit; Adopt acrylic copolymer or polyurethane and polymer electret material preparation to be used to repair the film pipe of neurotmesis among EP0286284A and the WO9005490A1 respectively; WO9403212A1 adopts hyaluronic acid ester matrix and the hyaluronic acid ester line enhancing structure that interweaves, and preparation is used to repair the conduit of peripheral nerve defection.Yet, these materials of being reported, perhaps preparation difficulty perhaps has certain defective aspect absorbability and the histocompatibility, or exists and be unfavorable for the factor of neuranagenesis, and the practical application of failing to obtain clinically.
" Chinese reconstruction surgical magazine " 7 (3): 169～171 (1993) and 12 (2): reported experimentation in 90～93 (1998) respectively with chitin (or claiming chitin, poly-N-acetyl-2-amino-2-deoxy-D-glucose) bridge joint peripheral nerve defection, and the experimentation of chitin and the chitosan and the Schwann cell compatibility.Toxic solvents in the former preparation process can't be removed fully, the goods poor stability; " chitosan " described in latter's experimentation is the aseptic air-dry back of 2% chitosan dilute acetic acid aqueous solution products therefrom, in the macromolecular structure-NH
2Group has been ionization state, and the chitosan of this " amino ionizing " does not possess anti-water solublity, can't make the film pipe with certain physical and mechanical properties and degraded and absorbed cycle, is used for mixed nerve regenerated gap socket.Above-mentioned research also finds to act in chitnous membrane and the neuranagenesis the too late chitosan of histocompatibility between the great Schwann cell.
Adopt the cross-linking agent glutaraldehyde to carry out crosslinked among the CN1262961 to chitosan (being called chitosan in the document), preparation is used to repair the conduit of neurologic defect, but this crosslinked meeting further influences the biocompatibility and the vivo degradation absorbent properties of chitosan (being called chitosan in the document).In fact, research worker of the present invention finds, even the chitosan of Non-crosslinked degraded and absorbed performance in vivo is also unsatisfactory, and with to a certain degree inflammatory reaction.Chinese in addition reconstruction surgical magazine 14 (3): also once pointed out in 175～179 (2000): the obvious inflammatory reaction around the chitosan may be increased relevantly with positive charge density, and the someone thinks that chitosan is not suitable as the in-vivo embed material simultaneously.Because above-mentioned research and mechanical performance of products and poor stability can not be applied to clinical.
In sum, chitosan (chitosan) does not possess anti-water solublity with the chitosan (chitosan) of " amino ionizing " that acetic acid forms, can't make the film pipe with certain physical and mechanical properties and degraded and absorbed cycle; Chitosan (chitosan) biocompatibility and the degraded and absorbed poor-performing in vivo that is not " amino ionizing ".As seen also there is not at present the material that is used to prepare artificial biological canula that a kind of biocompatibility is better, can absorb, have certain promotion and guide neuranagenesis effect, physical and mechanical properties and price to suit.
Sodium alginate is the natural polymer that is present in the Brown algae, has excellent biological compatibility and absorbability.But because its antibiosis reason saline poor performance does not see that so far it is used to prepare the report of absorbability artificial biological canula.
The content of invention
The object of the present invention is to provide a kind of artificial biological canula, described biological tube has the function of good histocompatibility, suitable degraded and absorbed cycle, guiding and promotion effective regeneration of nerve.
The object of the present invention is to provide a kind of manufacture method of artificial biological canula, described preparation method is simple, good product performance, suitability for industrialized production.
To achieve these goals, the technical solution used in the present invention is, a kind of artificial biological canula, described biological tube are that tube wall comprises alginic acid, chitosan and calcium alginate, and its weight ratio is an alginic acid: chitosan: calcium alginate is 1: 0.7: 0.3-1: 1: 0.7 hollow sleeve.
The molecular weight of described alginic acid, calcium alginate is 20-65 ten thousand.Described chitosan (or claim chitosan, chitosan) is extracted by the shell of Eriocheir sinensis, shrimp for the method that adopts prior art and obtains, and preferred molecular weight is 15～500,000, and deacetylation is 70～90%.
Further comprise short nerve growth factor in the described artificial biological canula, its weight content is: alginic acid: chitosan: calcium alginate: short nerve growth factor 1: 0.7: 0.3: 0.007-1: 1: 0.7: 0.3.
Described short nerve growth factor is NGF, bFGF, compound recipe Radix Hedysari injection, schwann cell or is fit to of the present invention other and promotes the medicine or the active matter of nerve growths, also can be its more than one combination.
Described artificial biological canula internal diameter is 0.7-6mm, wall thickness 0.1-2mm.When being used for animal reparation neurologic defect, bore is preferably 0.7-1.5mm, and wall thickness is 0.1-0.2mm; When being used for human body, bore is preferably 1-6mm when clinical, and wall thickness is 1-2mm, the size of the nerve that concrete size is repaired as required and deciding.
The manufacture method of artificial biological canula of the present invention is, sodium alginate is made spinning solution, under extraneous and sandwich layer coagulating bath effect, make alginic acid-calcium alginate hollow circular tube through doughnut spinning and draft process, the hollow circular tube washing is extremely neutral, dilute acetic acid solution with chitosan carries out chemical treatment to the gained hollow circular tube, obtains having antibiosis reason saline performance and the alginic acid in suitable degraded and absorbed cycle chitosan-calcium alginate artificial biological canula through post processing again.
Wherein said doughnut spinning and draft process comprise: spinning solution is through metering, extrude from the cortex of hollow spinneret orifice, make sodium alginate be converted into the coagulating bath that alginic acid-calcium alginate or calcium alginate are solidified thereby directly enter, meanwhile, described coagulation bath is extruded from the sandwich layer of hollow spinneret orifice, spinning solution after extruding is solidified under acting in extraneous coagulating bath and sandwich layer coagulant, draw first break draft through deflector roll, obtain the alginic acid-calcium alginate hollow circular tube of the neural size of successive suitable reparation.
Wherein, the manufacture method of described artificial biological canula further comprises: handle washing to neutral alginic acid-calcium alginate hollow circular tube to part calcium alginate with dilute acetic acid solution and be converted into and be beneficial to and the bonded alginic acid of chitosan, the dilute acetic acid solution with chitosan carries out chemical treatment to described alginic acid-calcium alginate hollow circular tube again.
Further in the dilute acetic acid aqueous solution of spinning solution of the present invention, coagulating bath, dilute acetic acid aqueous solution and chitosan, be added with short nerve growth factor respectively, make that each composition weight content is in the medicament slow release type artificial biological canula that makes: alginic acid: chitosan: calcium alginate: short nerve growth factor 1: 0.7: 0.3: 0.007--1: 1: 0.7: 0.3.After adding short nerve growth factor, the temperature of each process procedure all is controlled to be 1-10 ℃.
The manufacture method of a kind of artificial biological canula of the present invention can also for: chitosan is dissolved in the dilute acetic acid aqueous solution, obtains the dilute acetic acid aqueous solution of chitosan.With the mixed liquid dipping of slim nonwoven acupuncture calcium alginate fibre net with aqueous acetic acid and acetone, dewater with acetone in the washing back, air-dry, slim nonwoven acupuncture calcium alginate fibre net after will handling then fully floods with the dilute acetic acid aqueous solution of above-mentioned chitosan, taking out the back is roller bearing with the politef cylindrical rod that is fit to the neural size of reparation, make above-mentioned fleece on roller bearing, closely be wound to the pipe thickness that is fit to repair neural size through impregnation process, temperature when having nerve growth factor to exist in the above-mentioned technical process is controlled to be 4～10 ℃, place the freezer dryer lyophilization then, obtain alginic acid chitosan-calcium alginate artificial biological canula.
The molecular weight of sodium alginate of the present invention is 20-65 ten thousand, and concentration is 3-10wt%.The concentration of the dilute acetic acid aqueous solution of chitosan is 0.5-3wt% chitosan and 0.5-5wt% spirit of vinegar, and the molecular weight of chitosan is 15～500,000, and deacetylation is 70～90%.
Among the present invention, further in spinning solution, add short nerve growth factor with respect to sodium alginate weight 1-15%.
Coagulating bath of the present invention is mixed aqueous solution a kind of of the mixed aqueous solution of calcium chloride water, calcium chloride and hydrochloric acid or calcium chloride and short nerve growth factor, and its concentration is respectively the hydrochloric acid of preferred 0.5-2wt%, the calcium chloride of 0.7-10wt% and the short nerve growth factor of 0.1-6wt%.
The mixed solution washing, the reuse dehydrant dehydration back that wherein with hollow circular tube washing to neutral process are water and dehydrant are air-dry, and described dehydrant is acetone, methanol or ethanol.
Wherein handle washing to neutral alginic acid-calcium alginate hollow circular tube to part calcium alginate and be converted in the technical process that is beneficial to the bonded alginic acid of chitosan, can add nerve growth factor with dilute acetic acid solution; The concentration of treatment fluid is respectively the nerve growth factor of 0.1-6wt%, the dilute acetic acid aqueous solution of 0.5-5wt%, and bath raio is an artificial biological canula: treatment fluid 1: 5～1: 20wt.
The concentration of adding nerve growth factor in the dilute acetic acid aqueous solution of the chitosan of 0.5-3wt% chitosan and 0.5-5wt% spirit of vinegar is 0.5-3%.
Described post processing for after the reagent dehydration again with reagent wash and to be immersed in the medical alcohol sterilization standby; Or in 2～8 ℃ of following refrigerators, to preserve standby (sterile working) after the freezer dryer lyophilization.Described reagent is volatile reagent or its mixed solutions such as methanol, ethanol, acetone.
Specifically, the manufacture method of a kind of artificial biological canula of the present invention is: with biology absorbable sodium alginate be dissolved in the water, obtain the high viscosity solution that concentration is 3-10wt%, vacuumizing and defoaming is to obtaining still spinning solution.Spinning solution is extruded from still with the 0.3-0.8MPa air pressure, through the spinning pump metering, extrude from the cortex of hollow spinneret orifice, directly enter coagulating bath, meanwhile, with the air pressure of 0.1-0.5MPa above-mentioned coagulation bath is extruded from the sandwich layer of hollow spinneret orifice.Spinning solution after extruding is solidified under acting in extraneous coagulating bath and sandwich layer coagulant, draws first break draft 1.1-2.5 doubly through deflector roll, obtains the alginic acid-calcium alginate hollow circular tube of the neural size of successive suitable reparation.To neutral, alginic acid in the alginic acid that obtains-calcium alginate hollow circular tube: the ratio of calcium alginate is 1: 0.3～1: 0.7 with the hollow circular tube washing; Place the dilute acetic acid aqueous solution of chitosan to soak chemical treatment to alginic acid then: chitosan: the calcium alginate weight ratio is 1: 0.7: 0.3--1: took out the back in 1: 0.7, carries out post processing again.
Described short nerve growth factor is for promoting the medicine or the active matter of nerve growth, can be commercially available NGF (nerve growth factor), bFGF (basic fibroblast growth factor), compound recipe Radix Hedysari injection, schwann cell or medicine or the active matter that is fit to other promotion nerve growths of the present invention, also can be its more than one combination, be weight ratio NGF: bFGF as short nerve growth factor: compound recipe Radix Hedysari injection=1: 1: 1.5-1: 2: 3.The gained artificial biological canula is brought said medicine in the body into as carrier, and slow release is in the part, thereby plays the effect that promotes neuranagenesis.
In the above-mentioned preparation method, further comprise nerve growth factor added in the chitosan solution of above-mentioned dilution and stir evenly, obtain chitosan-nerve growth factor mixed liquor, the slim nonwoven acupuncture calcium alginate fibre net after will handling then fully floods with above-mentioned chitosan-nerve growth factor mixed liquor.Temperature in the above-mentioned technical process is controlled to be 4～10 ℃.
Alginic acid is the natural polymer that is present in the Brown algae, is to be formed by the D type mannuronic acid (M) of β-1,4 structure and L type guluronic acid (G) copolymerization of α-1,4 structure from its structure, has excellent biological compatibility and absorbability.Owing on the chitosan strand a large amount of primary amino radicals is arranged, a large amount of carboxyls is arranged on the strand of alginic acid, so chitosan and alginic acid can form polyelectrolyte by positive and negative charge attraction, thereby make alginic acid obtain good antibiosis reason saline solubility, make " the amino ionizing " of chitosan simultaneously, to improve the anti-water solublity of chitosan.Reaction equation is as follows:
After alginic acid of the present invention-calcium alginate hollow pipe is handled through chitosan, owing to form polyelectrolyte, artificial biological canula antibiosis reason saline solubility is improved, and make the absorption cycle stretch-out, therefore control the chitosan content in the composite, obtain having good the antibiosis reason saline solubility and the artificial biological canula in the absorption cycle that suits.
Among the present invention, because macromole is subjected to stretch orientation in spinning and drafting process, thereby the gained hollow circular tube has toughness and is difficult for embrittlement, make the antibiosis reason salt aqueous of product obtain surprising raising simultaneously behind chitosan and the alginic acid chemical combination, thereby solved the problem of alginate and " amino ionizing " anti-poorly water-soluble of chitosan.
The absorbability artificial biological canula of Zhi Zaoing according to the method described above, good biocompatibility is to organism avirulence and inflammatory reaction.Be easy to degradation in vivo and absorb, the degraded and absorbed cycle suits and can artificial adjustment.Can promote Schwann cell growth and suppress growth of fibroblasts, the promotion neuranagenesis factor of adding can slow release in the neural broken ends of fractured bone, thereby play guiding and promote the effect of effective regeneration of nerve.Be placed between the two neural broken ends of fractured bone, carry out the socket of little gap, can make complicated neural restorative procedure simplification, sequencing, and obtain desirable regeneration effect, thereby can substitute the method for traditional adventitia suture in situ in the peripheral nerve reparation.
Below be specific embodiments of the invention, described embodiment is used to describe the present invention, rather than restriction the present invention.NGF among the embodiment (nerve growth factor), by biological product inspection center of The 2nd Army Medical College provide, bFGF (basic fibroblast growth factor), by LiZhu Medicine Group Co., Ltd provide, compound recipe Radix Hedysari injection provides jointly by institute of pediatrics, Beijing and The People's Hospital of Peking University.
The specific embodiment
Embodiment 1
With commercially available molecular weight is that 50 Wan-hai's sodium alginates are dissolved in the water, and (W: the W) high viscosity solution of concentration, vacuumizing and defoaming is to obtaining still spinning solution to obtain concentration and be 6%.Spinning solution is extruded from still with the 0.6MPa air pressure, through the spinning pump metering, extrude from the cortex of hollow spinneret orifice, directly enter coagulating bath, coagulating bath is 1.5% hydrochloric acid (W: W) with 0.5% calcium chloride (W: W) aqueous solution.Meanwhile, with the air pressure of 0.2MPa above-mentioned coagulation bath is extruded from the sandwich layer of hollow spinneret orifice.Spinning solution after extruding is solidified under acting in extraneous coagulating bath and sandwich layer coagulant, draws 1.4 times of first break draft through deflector roll, obtains successive alginic acid-calcium alginate hollow circular tube, round tube inside diameter 0.95mm, pipe thickness 0.2mm.With the hollow circular tube water: (V: mixed solution V) washs the pH=6.8 to mixed liquor to acetone=50: 50, and air-dry with acetone dehydration back, alginic acid in the alginic acid that obtains-calcium alginate hollow circular tube: the ratio of calcium alginate is 10: 4.3; Place then that to contain deacetylation be 82%, molecular weight 500,000 chitosan 1wt% (W: in 2wt% dilute acetic acid aqueous solution W), be dipped to the alginic acid of chitosan alginate-calcium alginate hollow circular tube under the room temperature: chitosan: the weight ratio of calcium alginate is 1: 0.91: 0.43, with behind the methanol dehydration again with 75% washing with alcohol, it is standby to be soaked in 75% ethanol sterilization after the washing.
The common peroneal nerve of SD rat is told about 5mm place, back to cut off, cut-off part stays the 2mm gap, to from 75% ethanol, take out and place between neural two broken ends of fractured bone with alginic acid carapace amine salt-calcium alginate artificial biological canula standby after the distilled water rinsing, doing 1 needle guard tube wall epineurium hanging wire with the 9-0 suture sews up, add seam 1 pin in offside sleeve end and epineurium surface then, neural two broken ends of fractured bone are respectively embedded in the sleeve pipe.Postoperative the 3rd all microscopically anatomic observations, former otch is dissected common peroneal nerve and alginic acid chitosan-calcium alginate artificial biological canula bridge connector, does not have inflammatory reaction around the bridge connector, does not have adhesion with surrounding tissue, and it is clear to demarcate, no cicatrix sample tissue.Tube wall does not have and subsides, and neural near, far-end and tube chamber do not have and come off.Tube wall fragility after 6 weeks is carefully peelled off tube wall, sees that the near-end nerve is connected with distal nerve, does not have cicatrix and adhesion in neural junction.10 weeks back gross examination of skeletal muscle appearance exhibition toe reflex, the microscopically anatomic observation sees that artificial biological canula is organized absorption substantially.With the sleeve pipe bridging part with the fixing dyeing of 1% osmic acid after, the stringer section of making cross-section section of 3～5 μ m and 10 μ m, optical microscope is observed down and the counting myelinated nerve fiber, the myelinated nerve fiber number in 10 * 40 times of following unit visuals field is 9.57.Get nearly stitch points tip side 5mm nerve segment, 2.5% glutaraldehyde is fixed, make ultrathin section behind 812 resin embeddings, scanning electron microscope is observed down, under 4000～10000 times of magnified sweep Electronic Speculum, visible myelinated nerve fiber is intensive, and myelin physically well develops, the myelin side is the schwann cell kytoplasm as seen, and can see the layering of myelin.
Embodiment 2
Other is with embodiment 1, different is adopts and contains 7wt% (with respect to sodium alginate weight) nerve growth factor (NGF: bFGF: 4wt% sodium alginate aqueous solution compound recipe Radix Hedysari injection=1: 1: 1.5 weight ratio) is a spinning solution, and adopt the hollow spinneret orifice of corresponding caliber and wall thickness, coagulating bath is the aqueous solution that contains 1.5% calcium chloride and 0.3% nerve growth factor.The calcium alginate hollow circular tube that obtains is to contain three (bath raioes 1: 10w: w of 0.5% dilute acetic acid aqueous solution repeated treatments of 0.3% nerve growth factor, each 20 minutes processing times), what obtain contains alginic acid in medicine alginic acid-calcium alginate hollow circular tube: calcium alginate: the ratio of nerve growth factor is 10: 3.8: 1, place then and contain deacetylation 82%, chitosan 0.7% (the W: W) of molecular weight 150,000, contain in 0.5% dilute acetic acid aqueous solution of nerve growth factor 0.3%, take out after 30 minutes, the temperature of each process procedure all is controlled to be 4～10 ℃ in the whole process of preparation, taking-up is placed on lyophilization in the freeze drying box, gained alginic acid: the alginic acid of chitosan-calcium alginate hollow circular tube: chitosan: calcium alginate: the ratio of nerve growth factor is 1: 0.81: 0.38: 0.1, round tube inside diameter 1.5mm, pipe thickness 0.2mm.Resulting product 2～8 ℃ of preservations in refrigerator are standby.In the 3rd week of postoperative, microscopically anatomic observation, former otch are dissected common peroneal nerve and are contained the artificial biological canula bridge connector of slow releasing pharmaceutical, do not have inflammatory reaction around the bridge connector, do not have adhesion with surrounding tissue, and it is clear to demarcate, no cicatrix sample tissue.Tube wall does not have and subsides, and neural near, far-end and tube chamber do not have and come off.Tube wall fragility after 6 weeks is carefully peelled off tube wall, sees that the near-end nerve is connected with distal nerve, does not have cicatrix and adhesion in neural junction.9 weeks back gross examination of skeletal muscle appearance exhibition toe reflex, the microscopically anatomic observation sees that sleeve pipe is organized absorption substantially.With the sleeve pipe bridging part with the fixing dyeing of 1% osmic acid after, the stringer section of making cross-section section of 3～5 μ m and 10 μ m, optical microscope is observed down and the counting myelinated nerve fiber, the myelinated nerve fiber number in 10 * 40 times of following unit visuals field is 9.72.Get nearly stitch points tip side 5mm nerve segment, 2.5% glutaraldehyde is fixed, make ultrathin section behind 812 resin embeddings, scanning electron microscope is observed down, under 4000～10000 times of magnified sweep Electronic Speculum, visible myelinated nerve fiber is intensive, and myelin physically well develops, the myelin side is the schwann cell kytoplasm as seen, and can see the layering of myelin.
Embodiment 3
The chitosan of deacetylation 89%, molecular weight 360,000 is dissolved in 2% dilute acetic acid aqueous solution, obtains the solution of chitosan concentration 5%.This chitosan solution is under agitation dripped distilled water, make it to be diluted to acetate concentration 0.5%, chitosan concentration 1.25%.Will be with respect to the nerve growth factor (NGF: bFGF: compound recipe Radix Hedysari injection=1: 1: 1.5 weight ratio) stir evenly in the chitosan solution of the above-mentioned dilution of adding, obtain chitosan-nerve growth factor mixed liquor of chitosan weight 28%.With slim nonwoven acupuncture calcium alginate fibre net (30 grams: rice 2 specifications, textile scientific research institute produces) use 2% aqueous acetic acid: the mixed liquid dipping of acetone=50: 50, dewater with pure acetone after washing three times, air-dry, use chitosan-nerve growth factor mixed liquor fully to flood then 20 minutes, the taking-up back is that the politef cylindrical rod of 6mm is a roller bearing with the diameter, make above-mentioned fleece on roller bearing, closely be wound to required pipe thickness (temperature when having nerve growth factor to exist in the above-mentioned technical process is controlled to be 4～10 ℃) through impregnation process, place the freezer dryer lyophilization then, obtain alginic acid: chitosan: calcium alginate: the nerve growth factor ratio is 10: 9.7: 3.3: 2.2 hollow circular tube, round tube inside diameter 6mm, pipe thickness 2mm.
Performances such as the intensity of in vitro tests and animal experiment proof product, anti-water solublity, bio-absorbable, inflammatory reaction all meet the requirements, and the product of this dimensions can be used for clinical.
Embodiment 4-6
The basic method that adopts embodiment 2, difference sees Table 1.
Table 1
| Embodiment 4 | Embodiment 5 | Embodiment 6 | |
| Spinning solutionThe red stilbene liquid of sodium alginate molecular weight (ten thousand) concentration (%) pressure (MPa) nerve growth factor (%) (with respect to Na-alginate) NGF (%) bFGF (%) compound (%) | ?22 ?10 ?0.3 ?1 ?1 | ?39 ?6 ?0.8 ?10 ?5 ?5 | ?61 ?3 ?0.5 ?15 ?4 ?4 ?7 |
| The coagulating bath aqueous solutionCalcium chloride (%) * nerve growth factor (%) | ?10 ?NGF?0.1 | 51 (compound 1: 3: 4) | 0.7 6 (compound 1: 2: 3) |
| Acetic acid treatment fluid (for the first time)* nerve growth factor (%) spirit of vinegar (%) | NGF 0.1 1 (handling three times) | 1 (compound 1: 3: 4) 5 (processing secondary) | 6 (compound 1: 2: 3) 1 (handling three times) |
| Chitosan treatment fluid (second Inferior):Deacetylation (%) molecular weight (ten thousand) concentration (%) nerve growth factor (%) temperature (℃) | ?70 ?50 ?0.5 ?NGF?0.1 ?1 | 82 30 1.5 1 (compound 1: 3: 4) 4 | 90 15 36 (compound 1: 2: 3) 10 |
| Product alginic acid: chitosan: calcium alginate: nerve growth factor internal diameter (mm) wall thickness (mm) | ?1∶0.72∶0.62∶0 ?.007 ?0.7 ?0.1 | ?1∶0.86∶0.46∶0. ?07 ?1.2 ?0.18 | ?1∶0.91∶0.39∶0.12 ?1.5 ?0.2 |
| The anti-water-soluble biological of performance intensity absorbs the reaction of inflammatory reaction exhibition toe | Good general 5 weeks did not have for 10 weeks | Good 7 weeks did not have for 10 weeks | Good 8 weeks did not have for 9 weeks |
* the composite nerve somatomedin in the table is NGF: bFGF: compound recipe Radix Hedysari injection.
Can prepare round tube inside diameter 2 or 4mm according to the method for embodiment 1 or 2 in addition, the artificial biological canula of pipe thickness 1 or 1.5mm is used for human body repair deficiency nerve clinically, and is functional.
Claims (11)
1. an artificial biological canula is characterized in that the tube wall of described artificial biological canula comprises alginic acid chitosan and calcium alginate, and its weight ratio is an alginic acid: chitosan: calcium alginate is 1: 0.7: 0.3-1: 1: 7 hollow sleeve.
2. a kind of artificial biological canula according to claim 1, it is characterized in that further comprising in the described artificial biological canula short nerve growth factor, its weight ratio is: alginic acid: chitosan: calcium alginate: short nerve growth factor 1: 0.7: 0.3: 0.007-1: 1: 0.7: 0.3, described short nerve growth factor was one or more the combination of NGF, bFGF, compound recipe Radix Hedysari injection, schwann cell.
3. a kind of artificial biological canula according to claim 1 and 2, the molecular weight that it is characterized in that alginic acid, calcium alginate is 20～650,000, and the chitosan molecular weight is 15～500,000, and deacetylation is 70～90%.
4. a kind of artificial biological canula according to claim 1 and 2 is characterized in that described artificial biological canula internal diameter is 0.7-6mm, wall thickness 0.1-2mm; The bore that is used for the artificial biological canula of animal reparation neurologic defect is 0.7-1.5mm, and wall thickness is 0.1-0.2mm; The clinical bore that is used to repair the artificial biological canula of people's neurologic defect is 1-6mm, and wall thickness is 1-2mm.
5. the preparation method of the described artificial biological canula of claim 1, comprise sodium alginate is made spinning solution, under extraneous and sandwich layer coagulating bath effect, make alginic acid-calcium alginate hollow circular tube through doughnut spinning and draft process, the hollow circular tube washing is extremely neutral, dilute acetic acid solution with chitosan carries out chemical treatment to the gained hollow circular tube, obtains having antibiosis reason saline performance and the alginic acid in suitable degraded and absorbed cycle chitosan-calcium alginate artificial biological canula through post processing again.
6. the preparation method of according to claim 5-kind of artificial biological canula, described preparation method comprises: with biology absorbable molecular weight be that 20～650,000 sodium alginate is dissolved in the water, obtain the high viscosity solution that concentration is 3-10wt%, vacuumizing and defoaming is to obtaining still spinning solution; Spinning solution is extruded from still with the 0.3-0.8MPa air pressure, through the spinning pump metering, extrude from the cortex of hollow spinneret orifice, directly enter coagulating bath, meanwhile, with the air pressure of 0.1-0.5MPa above-mentioned coagulation bath is extruded from the sandwich layer of hollow spinneret orifice; Spinning solution after extruding is solidified under acting in extraneous coagulating bath and sandwich layer coagulant, draws first break draft 1.1-2.5 doubly through deflector roll, obtains the alginic acid-calcium alginate hollow circular tube of the neural size of successive suitable reparation; To neutral, alginic acid in the alginic acid that obtains-calcium alginate hollow circular tube: the ratio of calcium alginate is 1: 0.3～1: 0.7 with the hollow circular tube washing; Placing molecular weight then is 15～500,000, and deacetylation is to soak chemical treatment in the dilute acetic acid aqueous solution of 70～90% chitosan to alginic acid: chitosan: the calcium alginate weight ratio is 1: 0.7: 0.3-1: took out the back in 1: 0.7, carries out post processing again.
7. the preparation method of a kind of artificial biological canula according to claim 5, the manufacture method of wherein said artificial biological canula further comprises: handle washing to neutral alginic acid-calcium alginate hollow circular tube to part calcium alginate with the 0.5-5wt% dilute acetic acid aqueous solution and be converted into and be beneficial to and the bonded alginic acid of chitosan, the dilute acetic acid solution with chitosan carries out chemical treatment to described alginic acid-calcium alginate hollow circular tube again; The concentration of the dilute acetic acid aqueous solution of described chitosan is chitosan 0.5-3wt%, spirit of vinegar 0.5-5wt%.
8. according to the preparation method of any one described a kind of artificial biological canula of claim 5-7, further in the dilute acetic acid aqueous solution of described spinning solution, coagulating bath, dilute acetic acid aqueous solution and chitosan, be added with short nerve growth factor, make medicament slow release type artificial biological canula at 1-10 ℃, described short nerve growth factor is one or more the combination of NGF, bFGF, compound recipe Radix Hedysari injection, schwann cell.
9. according to the preparation method of a kind of artificial biological canula according to claim 8, described coagulating bath is mixed aqueous solution a kind of of the mixed aqueous solution of calcium chloride water, calcium chloride and hydrochloric acid or calcium chloride and short nerve growth factor, its concentration be respectively the calcium chloride of hydrochloric acid, 0.7-10wt% of 0.5-2wt% and 0.1-6wt% short nerve growth factor;
Wherein in described spinning solution, add short nerve growth factor with respect to sodium alginate weight 1-15%;
The mixed solution washing, the reuse dehydrant dehydration back that wherein with hollow circular tube washing to neutral process are water and dehydrant are air-dry, and described dehydrant is acetone, methanol or ethanol;
Wherein handle washing to neutral alginic acid-calcium alginate hollow circular tube to part calcium alginate and be converted in the technical process that is beneficial to the bonded alginic acid of chitosan, add the nerve growth factor of 0.1-6wt% with dilute acetic acid solution;
The concentration of adding nerve growth factor in the dilute acetic acid aqueous solution of the chitosan of 0.5-3wt% chitosan and 0.5-5wt% spirit of vinegar is 0.5-3wt%;
Described post processing for after the reagent dehydration again with reagent wash and to be immersed in the medical alcohol sterilization standby; Or in 2～8 ℃ of following refrigerators, to preserve standby (sterile working) after the freezer dryer lyophilization; Described reagent is volatile reagent or its mixed solutions such as methanol, ethanol, acetone.
10. the preparation method of the described artificial biological canula of claim 1, comprise that with molecular weight be 15～500,000, deacetylation is that 70～90% chitosan are dissolved in the dilute acetic acid aqueous solution, obtaining chitosan concentration is 0.5-3wt%, the chitosan dilute acetic acid aqueous solution of spirit of vinegar concentration 0.5-5wt%, with the mixed liquid dipping of slim nonwoven acupuncture calcium alginate fibre net with aqueous acetic acid and acetone, dewater with acetone in the washing back, air-dry, slim nonwoven acupuncture calcium alginate fibre net after will handling then fully floods with the dilute acetic acid aqueous solution of above-mentioned chitosan, taking out the back is roller bearing with the politef cylindrical rod that is fit to the neural size of reparation, make above-mentioned fleece on roller bearing, closely be wound to the pipe thickness that is fit to repair neural size through impregnation process, place the freezer dryer lyophilization then, obtain the alginic acid chitosan--the calcium alginate artificial biological canula; Described artificial biological canula internal diameter is 0.7-6mm, wall thickness 0.1-2mm; The bore that is used for the artificial biological canula of animal reparation neurologic defect is 0.7-1.5mm, and wall thickness is 0.1-0.2mm; The clinical bore that is used to repair the artificial biological canula of people's neurologic defect is 1-6mm, and wall thickness is 1-2mm.
11. the preparation method of a kind of artificial biological canula according to claim 10, comprising further that the nerve growth factor that will add 0.1-6wt% adds in the chitosan solution of dilution stirs evenly, obtain chitosan-nerve growth factor mixed liquor, the slim nonwoven acupuncture calcium alginate fibre net after will handling then fully floods with above-mentioned chitosan-nerve growth factor mixed liquor; The temperature of above-mentioned technical process is controlled to be 4～10 ℃.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01134542 CN1239207C (en) | 2001-11-06 | 2001-11-06 | Artificial biological canula and its making process |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 01134542 CN1239207C (en) | 2001-11-06 | 2001-11-06 | Artificial biological canula and its making process |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1416914A true CN1416914A (en) | 2003-05-14 |
| CN1239207C CN1239207C (en) | 2006-02-01 |
Family
ID=4672577
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 01134542 Expired - Lifetime CN1239207C (en) | 2001-11-06 | 2001-11-06 | Artificial biological canula and its making process |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1239207C (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101322860B (en) * | 2007-06-12 | 2012-01-11 | 中南大学 | Degradable blood vessel anastomosis casing tube and preparation thereof |
| CN103371857A (en) * | 2012-04-12 | 2013-10-30 | 北京汇福康医疗技术有限公司 | Composite biological cannula and preparation method and application thereof |
| CN105688273A (en) * | 2016-03-18 | 2016-06-22 | 南开大学 | Preparation method for sodium alginate hydrogel hollow tubes |
| CN105833342A (en) * | 2016-03-18 | 2016-08-10 | 南开大学 | Preparation method for sodium alginate hydrogel hollow tube with controllable inner diameter |
| CN107469144A (en) * | 2017-07-29 | 2017-12-15 | 青岛慧生惠众生物科技有限公司 | A kind of chitosan-based composite nerve conduit and its preparation method and application |
| CN110541209A (en) * | 2019-09-19 | 2019-12-06 | 东华大学 | Continuous preparation method of hydrogel optical fiber based on reactive spinning |
| CN110721345A (en) * | 2018-07-17 | 2020-01-24 | 中国科学院大连化学物理研究所 | Preparation method of ultrathin cavity composite microfiber material for encapsulating cells |
-
2001
- 2001-11-06 CN CN 01134542 patent/CN1239207C/en not_active Expired - Lifetime
Cited By (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101322860B (en) * | 2007-06-12 | 2012-01-11 | 中南大学 | Degradable blood vessel anastomosis casing tube and preparation thereof |
| CN103371857A (en) * | 2012-04-12 | 2013-10-30 | 北京汇福康医疗技术有限公司 | Composite biological cannula and preparation method and application thereof |
| CN105688273A (en) * | 2016-03-18 | 2016-06-22 | 南开大学 | Preparation method for sodium alginate hydrogel hollow tubes |
| CN105833342A (en) * | 2016-03-18 | 2016-08-10 | 南开大学 | Preparation method for sodium alginate hydrogel hollow tube with controllable inner diameter |
| CN107469144A (en) * | 2017-07-29 | 2017-12-15 | 青岛慧生惠众生物科技有限公司 | A kind of chitosan-based composite nerve conduit and its preparation method and application |
| CN110721345A (en) * | 2018-07-17 | 2020-01-24 | 中国科学院大连化学物理研究所 | Preparation method of ultrathin cavity composite microfiber material for encapsulating cells |
| CN110541209A (en) * | 2019-09-19 | 2019-12-06 | 东华大学 | Continuous preparation method of hydrogel optical fiber based on reactive spinning |
| CN110541209B (en) * | 2019-09-19 | 2021-08-10 | 东华大学 | Continuous preparation method of hydrogel optical fiber based on reactive spinning |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1239207C (en) | 2006-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69728054T2 (en) | BIORESORABLE SEALING POINTS FOR POROUS ARTIFICIAL VESSELS | |
| US10245353B2 (en) | Hydrophilic electrospinning biological composite stent material used for tissue regeneration and preparation method and application thereof | |
| CN100479785C (en) | Producing method for double-layer artificial nerve catheter | |
| CN106729980B (en) | A kind of bionical nerve graft and preparation method thereof for peripheral nerve reparation | |
| CN112553785B (en) | Double-layer guided tissue regeneration membrane and preparation method thereof | |
| KR20070118730A (en) | Wound dressing materials with excellent ability to moisturized skin and method of manufacturing the same | |
| RU2621114C2 (en) | Polysaccharide fibers for wound dressings | |
| CN1235646C (en) | Method for preparing multifunctional biological repair material | |
| CN109267240A (en) | A kind of medical dressing chitosan/calcium alginate needleless electrostatic spinning nano fiber film and preparation method thereof | |
| CN1239207C (en) | Artificial biological canula and its making process | |
| CN111962210A (en) | Polycaprolactone/methacryloylated elastin nanofiber composite membrane and preparation method and application thereof | |
| KR20150090135A (en) | Endless fibres on the basis of hyaluronan selectively oxidized in the position 6 of the n-acetyl-d-glucosamine group, preparation and use thereof, threads, staples, yarns, fabrics made thereof and method for modifying the same | |
| CN110499541B (en) | High-strength bionic fiber based on collagen liquid crystal in-situ self-assembly and preparation method thereof | |
| CN106668950A (en) | Fibroin three-dimensional bracket for nervus centralis remediation | |
| CN111501121A (en) | Method for preparing collagen fiber by wet spinning | |
| CN114225090A (en) | Chitosan-based nanofiber wound dressing with adhesion and antibacterial performance and preparation method thereof | |
| CN1185021C (en) | Partial chitosan bio-canula capable of inducing and promoting effective regeneration of nerve and its preparation method | |
| CN110354316A (en) | A kind of compound tendon Antiadhesive film and the preparation method and application thereof | |
| CN104225682A (en) | A three-dimensional patch used for nerve regeneration and epidural restoration and a preparing method thereof | |
| JP3790720B2 (en) | Composite fiber | |
| CN110721348B (en) | Natural silk reinforced hydroxyapatite/chitosan composite membrane and preparation method thereof | |
| CN115531613B (en) | Nerve graft conduit filled with porous stent material, preparation method and application | |
| CN1298298C (en) | Preparation method of chitosan tubular bracket | |
| CN115192764B (en) | Preparation method and application of degradable and absorbable surgical suture based on casein | |
| JP4085113B2 (en) | Composite fiber |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: BEIJING HUIFUKANG MEDICAL TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: BEIJING YIMIN WEIKANG TECHNOLOGY CO., LTD. Effective date: 20100122 Owner name: BEIJING YIMIN WEIKANG TECHNOLOGY CO., LTD. Free format text: FORMER OWNER: CHINESE TEXTILE ACADEMY Effective date: 20100122 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20100122 Address after: Building 20, Kang Sheng Industrial Park, 11 Kangding street, Yizhuang street, Beijing economic and Technological Development Zone, Patentee after: Beijing 3H Medical Technology Co.,Ltd. Address before: Beijing City, Chaoyang District No. 39 East Third Ring Road, SOHO District North office building A block 19 layer 2203 rooms zip code: 100020 Patentee before: Beijing Yimin Wei Kang Technology Co.,Ltd. Effective date of registration: 20100122 Address after: Beijing City, Chaoyang District No. 39 East Third Ring Road, SOHO District North office building A block 19 layer 2203 rooms zip code: 100020 Patentee after: Beijing Yimin Wei Kang Technology Co.,Ltd. Address before: 3 Chaoyang Li Zhong street, Chaoyang Gate, Beijing, zip code: 100025 Co-patentee before: PEKING UNIVERSITY PEOPLE'S Hospital Patentee before: CHINA TEXTILE ACADEMY |
|
| C56 | Change in the name or address of the patentee | ||
| CP03 | Change of name, title or address |
Address after: In Beijing economic and Technological Development Zone, two street 100176 8 Beijing City Hospital No. 18 building 3 layer, 4 layer, 5 layer 504-520 room Patentee after: BEIJING 3H MEDICAL TECHNOLOGY CO.,LTD. Address before: 100176 Beijing economic and Technological Development Zone, Kangding street, No., Kang Sheng Industrial Park, building 20, building 11 Patentee before: Beijing 3H Medical Technology Co.,Ltd. |
|
| CX01 | Expiry of patent term |
Granted publication date: 20060201 |
|
| CX01 | Expiry of patent term |